KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $93.0 million.

  • Johnson & Johnson's Asset Writedowns and Impairment changed N/A to $93.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.0 million, marking a year-over-year decrease of 8255.27%. This contributed to the annual value of $405.0 million for FY2024, which is 6872.59% down from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Asset Writedowns and Impairment is $93.0 million.
  • In the past 5 years, Johnson & Johnson's Asset Writedowns and Impairment registered a high of $1.0 billion during Q4 2021, and its lowest value of -$66.0 million during Q3 2021.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $185.0 million (2024), whereas its average is $245.6 million.
  • In the last 5 years, Johnson & Johnson's Asset Writedowns and Impairment tumbled by 16947.37% in 2021 and then skyrocketed by 425714.29% in 2022.
  • Over the past 5 years, Johnson & Johnson's Asset Writedowns and Impairment (Quarter) stood at $1.0 billion in 2021, then tumbled by 39.96% to $610.0 million in 2022, then decreased by 22.13% to $475.0 million in 2023, then plummeted by 94.53% to $26.0 million in 2024, then surged by 257.69% to $93.0 million in 2025.
  • Its last three reported values are $93.0 million in Q3 2025, $30.0 million for Q1 2025, and $26.0 million during Q4 2024.